CONTRACT FOR CARE · RIGHTS, CONSENT & GOVERNMENT POWER

Our Legal Case

A patient’s need for medicine should not become the pressure used to obtain a criminal admission. Examine compulsory disclosures, penalties for silence, coerced rights waivers, and the circumstances behind the signature.

Use the original agreement and policy sources for this record to identify the exact clause, its legal source, and the stated consequence. Preserve those facts before reaching a conclusion about a particular provider or condition.

Apply the constitutional and consent review to this record
  1. Government responsibility: Which law, binding rule, agency instruction, or public-provider policy requires the particular disclosure or consequence? Separate it from provider-added terms.
  2. Potential criminal admission: Identify the exact spoken answer, written history, certification, or explanation and the real criminal risk it creates.
  3. Penalty for silence: Record what happens if the patient invokes the privilege or refuses a rights waiver, including denial, discharge, or interruption of treatment.
  4. Consent and pressure: Preserve the circumstances of signing, severity of pain, accessible alternatives, and whether the patient could honestly accept the prospective obligations.
  5. Criminal-use protection: Identify legally sufficient immunity and limits on use of both the answer and evidence derived from it. A privacy assurance is a separate protection.

Read the precedents, evidence framework, clause review, and remedies and reform demands. The work develops a proposed constitutional challenge; applying it to a particular condition requires its facts and legal authority.

MASSACHUSETTS · CONTRACT FOR CARE

Pain and Wellness Center — Consent for Chronic Opioid Therapy

Public institutional form — current signed use unconfirmed

Document/version: URL/filename2026/06 and2026; PDF metadata title says2025; no printed effective date. 1 PDF page.

Consent is a separate document from clinic policy. Medical risk statements are reported as document contents, not independently validated medical advice; current use and year discrepancy remain open.

Requirements and documented consequences

This table paraphrases source-located terms. Use the original PDF for exact complete wording. PDF page numbers count from the first page, including packet covers.

Source locationRequirement summaryClassificationStated consequence
p.1, opening sectionsRisks, alternatives and uncertain pain benefit discussed.Required subject; method variesNo distinct penalty specified here.
p.1, disclosure sectionsDisclose medicines/history and notify other prescribers.Clinic term beyond §18A baselineNo distinct penalty specified here.
p.1, activity sectionAvoid dangerous activities when impaired.Clinic term beyond §18A baselineNo distinct penalty specified here.
p.1, interaction sectionAgreement bars specified opioid-interacting medicines.Legal review requiredPatient-specific appropriateness unresolved.
p.1, dependence/addiction sectionsDocument distinguishes physical dependence, tolerance and addiction.Required subject; method variesNo distinct penalty specified here.
p.1, final risk sectionsRecords sex-specific effects and pregnancy notification.Required subject; method variesNo distinct penalty specified here.
p.1, final paragraphVoluntary signature after questions.Required subject; method variesNo distinct penalty specified here.

Comparison with Massachusetts authority

M.G.L. c.94C §18A(b) requires an agreement addressing benefits and abuse/misuse risks when a registered practitioner recommends ER/LA opioids during long-term pain management. Record placement follows that subsection. Narrow hydrocodone professional rules, written informed-consent duties, and MassHealth coverage criteria are separate layers.

§18A does not itself prescribe these exact deadlines, charges, disclosure terms or dismissal mechanics. 243CMR2.07(25) addresses screening, counts and safe storage for a narrow formulation and patient-specific risk; §2.07(26) separately governs informed consent. A required subject does not make every implementation mandatory.

DIA’s October 2024 chronic-pain guideline addresses agreements, bilateral responsibilities and continuity within the injured-worker context. DIA says its guidelines are not mandates. Coverage terms must be mapped to the actual payer/program.

Connected offices

Current copy and practice response

Patients can submit the version presented to them. Practices can supply a current blank form, dates, applicable offices/groups, exceptions and corrections. Historical versions remain linked. No motive or legality finding is made. Privacy, termination, pregnancy-testing and partial-fill interpretations remain open for owner/legal review.

Research: October 12, 2026. Methodology. Factual comparison published with stated interpretation limits.